何小鵬:小鵬汽車(09868.HK)不會改名 以名字命名體現責任
內媒報道,對於有網友指小鵬汽車(09868.HK)(XPEV.US)的名字略有土氣,難以進軍高端市場,小鵬汽車創辦人兼行政總裁何小鵬指出,從去年就開始思考「小鵬名字太土」這個問題,經過深思熟慮之後,決定公司不會更換名字。
他以福特(F.US)、豐田(TM.US)、特斯拉(TSLA.US)等以姓氏命名的車企為例,稱以其名字命名品牌,是對小鵬汽車品牌認同和責任的表現。同時,他指小米(01810.HK)、小鵬名字內都有「小」,「小」字的發音對於歐美國家用戶有一定難度,但隨著中國品牌的崛起,歐美國家用戶會逐漸學會「小」字的發音。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.